April 13 (Reuters) - Medesis Pharma SA ALMDP.PA :
* ANNUAL ACTIVITIES & RESULTS 2021
* FOR THE FISCAL YEAR 2021 TURNOVER OF MEDESIS PHARMA
AMOUNTS TO
73,050 EUROS
* EQUITY AMOUNTS TO 1,646,099 EUROS AS OF DECEMBER 31, 2021
* CASH AT DECEMBER 31, 2021 AMOUNTED TO 2,889,232 EUROS
* OUTLOOK: TO CONTINUE THE DEVELOPMENT OF 4 PRIORITY DRUG
CANDIDATES, ADVANCEMENT OF THE COLLABORATION WITH TRANSGENE AND
POSSIBLE IMPLEMENTATION OF COLLABORATIVE PROGRAMS IN OTHER
AREAS, INCLUDING THE DEVELOPMENT OF TREATMENTS FOR NUCLEAR
CONTAMINATION
* OUTLOOK: CURRENTLY HAS SUFFICIENT CASH TO COVER ITS
ACTIVITIES
UNTIL THE END OF AUGUST 2022
Further company coverage: ALMDP.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48587696600;))